Search

everythinglearnresearchcommunity

for

Search:↓

Rosemary oil and minoxidil 2% both effectively increase hair count in people with androgenetic alopecia, but rosemary oil causes less scalp itching.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Topical finasteride is an effective and safer treatment for male hair loss.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

JAK inhibitors offer new hope for treating severe alopecia areata.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.